GE HealthCare shares rise as earnings beat and guidance raised

Published 30/07/2025, 11:40
© Reuters

Investing.com -- GE HealthCare Technologies Inc. reported second-quarter earnings that surpassed analyst expectations on Wednesday, as the medical technology company delivered solid revenue growth and raised its full-year outlook, sending shares up 3.5% in premarket trading.

The company posted adjusted earnings per share of $1.06, exceeding the analyst consensus of $0.92, while revenue reached $5.0 billion, slightly above the $4.97 billion analysts had expected. Revenue increased 3% YoY, or 2% on an organic basis, driven by strength in the U.S. and European markets.

GE HealthCare (NASDAQ:GEHC) raised its full-year 2025 guidance, now projecting organic revenue growth of approximately 3%, up from its previous forecast of 2% to 3%. The company also boosted its adjusted EBIT margin outlook to 15.2% to 15.4%, compared to its earlier guidance of 14.2% to 14.4%, and increased its free cash flow target to at least $1.4 billion from $1.2 billion previously. Adjusted EPS is expected to be in the range of $4.43 to $4.63, which includes approximately $0.45 of tariff impact. This compares to the previous Adjusted EPS guidance in the range of $3.90 to $4.10.

"We were pleased with solid orders and revenue performance in the second quarter across all segments, reflecting healthy customer investment in capital equipment," said GE HealthCare President and CEO Peter Arduini. "We also reported strong earnings performance while leveraging our lean capabilities and demonstrating progress on tariff mitigation."

The company’s Pharmaceutical (TADAWUL:2070) Diagnostics segment was the standout performer, with revenue jumping 14% YoY to $729 million. The Imaging segment, the company’s largest by revenue, saw a 2% increase to $2.2 billion.

GE HealthCare reported a book-to-bill ratio of 1.07 times, with total company orders increasing 3% organically YoY, suggesting continued momentum heading into the second half of the year.

Net income margin improved to 9.7% from 8.9% in the prior year, though adjusted EBIT margin declined to 14.6% from 15.3%, primarily due to tariff impacts that were partially offset by productivity improvements and higher volumes.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.